SlaybackPharma, a New Jersey-based company, is a leader in complex generic and specialty pharmaceutical products. With a dedicated team of 85 employees and operations in the U. S., India, and Europe, Slayback is known for its exceptional track record in developing and launching innovative medications.

Since its establishment in 2011, Slayback has received numerous sole first-to-file ANDAs, 505(b)(2)s, and complex generic approvals. They have recently made waves with their generic ANDA for Hydroxyprogesterone 5 ml vial, which became the first to be approved and launched in the U. S.

Slayback continues to dominate the market, holding the largest market share. Demonstrating their exceptional execution skills, Slayback has successfully obtained approvals and launched difficult products such as Propofol Injectable Emulsion. For inquiries or more information, please reach out to Slayback Pharma LLC at (+1) 609 945 3443 or contact@slayback-pharma.

com. Their office is located at 301 Carnegie Center, Suite 303, Princeton, NJ 08540. SlaybackPharma is committed to providing high-quality medications and making a positive impact in the healthcare industry